References
- Sundaram S, Trivedi R, Durairaj C, et al. Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res 2009;15:7299–7308
- Siegel R, Ward E, Brawley O, Jamel A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–236
- Kawabata A, Baoum A, Ohta N, et al. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 2012;72:2057–2067
- Kong F, Ge L, Liu X, et al. Mannan-modified PLGA nanoparticles for targeted gene delivery. Int J Photoenergy 2011;2012:926754
- Kong F, Zhou F, Ge L, et al. Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine 2012;7:1079–1089
- Jiang Z, Sun C, Yin Z, et al. Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems. Int J Nanomedicine 2012;7:2019–2031
- Selvamuthukumar S, Velmurugan R. Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis 2012;11:159. doi:10.1186/1476-511X-11-159
- Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131–S155
- Saupe A, Wissing SA, Lenk A, et al. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) – structural investigations on two different carrier systems. Bio-Med Mater Eng 2005;15:393–402
- Bellocq NC, Pun SH, Jensen GS, Davis ME. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 2003;14:1122–1132
- Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002;22:225–250
- Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011;63:161–169
- Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycoldiacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 2002;19:1424–1429
- Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145–160
- Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58:1532–1555
- Wang W, Zhou F, Ge L, et al. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine 2012;7:2513–2522
- Yu YH, Kim E, Park DE, et al. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur J Pharm Biopharm 2012;80:268–273
- Li P, Liu D, Miao L, et al. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomedicine 2012;7:925–939
- Kamiya H, Akita H, Harashima H. Pharmacokinetic and pharmacodynamic considerations in gene therapy. Drug Discov Today 2003;8:990–996
- Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 1999;5:443–451
- Yu W, Liu C, Liu Y, et al. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 2010;27:1584–1596